PUBLISHER: The Business Research Company | PRODUCT CODE: 1518314
PUBLISHER: The Business Research Company | PRODUCT CODE: 1518314
An external ventricular drain (EVD) is a medical device used to relieve elevated intracranial pressure (ICP) by draining cerebrospinal fluid (CSF) from the brain's ventricles to an external collection system. This helps prevent damage to brain tissues and alleviates symptoms such as headaches, nausea, and altered consciousness. The procedure is commonly used for patients with various disorders that cause an accumulation of excess CSF within the cranial cavity.
External ventricular drains come in two main types, external ventricular drainage sets and accessories. An external ventricular drainage set is a medical device employed to alleviate heightened intracranial pressure by redirecting cerebrospinal fluid from the brain's ventricles to an external collection system. Its applications span across various conditions such as traumatic brain injury, intracranial hemorrhage, hydrocephalus, and others. These devices are utilized by a range of end users including hospitals, specialty hospitals, specialty clinics, and others.
The external ventricular drain research report is one of a series of new reports from The Business Research Company that provides external ventricular drain market statistics, including the external ventricular drain industry's global market size, regional shares, competitors with an external ventricular drain market share, detailed external ventricular drain market segments, market trends and opportunities, and any further data you may need to thrive in the external ventricular drain industry. This external ventricular drain market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The external ventricular drain market size has grown strongly in recent years. It will grow from $4.43 billion in 2023 to $4.71 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to a rise in incidences of traumatic brain injuries (TBI), advancements in neurosurgery, the aging population, and regulatory support and standardization.
The external ventricular drain market size is expected to see strong growth in the next few years. It will grow to $6.07 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%. The projected growth during the forecast period can be credited to the rise in neurological disorders, the demand for minimally invasive procedures, the expansion of healthcare infrastructure, and the emphasis on patient outcomes. Key trends anticipated during this period involve the increasing adoption of minimally invasive techniques, the integration of advanced monitoring technologies, innovations in medical device designs, the development of external ventricular drains with antimicrobial properties, and the market's expansion in emerging economies.
The rising incidence of traumatic brain injuries (TBI) is anticipated to drive the expansion of the external ventricular drain market in the future. Traumatic brain injury (TBI) refers to damage to the brain caused by external force, which can lead to temporary or permanent impairment of cognitive, physical, and psychosocial functions. The increasing occurrence of traumatic brain injuries can be attributed to factors such as increased participation in contact sports, higher rates of motor vehicle accidents, and an aging population prone to falls. TBIs can cause elevated intracranial pressure (ICP) due to swelling, hemorrhage, or the accumulation of cerebrospinal fluid (CSF), all of which can result in further brain damage. External ventricular drains (EVDs) help mitigate these effects by draining excess CSF and continuously monitoring ICP. For example, in May 2024, according to the Florida Department of Health, a US-based government agency, the age-adjusted death rate from traumatic brain injury in Florida rose from 5,406 per 100,000 population in 2021 to 5,654 per 100,000 population in 2022, indicating an increase of approximately 4.59%. Therefore, the growing incidence of traumatic brain injuries is fueling the expansion of the external ventricular drain market.
Prominent companies within the external ventricular drain market are concentrating on developing innovative solutions, such as advanced fluid management systems, to advance the treatment of intracranial bleeding. These advanced fluid management systems encompass technologies that enhance the basic drainage function by incorporating features such as active irrigation, targeted therapies, real-time monitoring, or other functionalities to augment treatment efficacy and potentially improve patient outcomes. For example, in February 2022, IRRAS Inc., a US-based provider of commercial medical devices for neurocritical care, introduced the next-generation IRRAflow system, an advanced external ventricular drain equipped with automated irrigation to prevent blockages and enhance drainage, which is currently being introduced in the United States. This system enhances user experience through step-by-step tutorials, advanced data tracking, an intuitive interface, and optimized drainage options. It offers advanced fluid management to therapeutically treat critically ill patients with intracranial bleeding by incorporating continuous irrigation that dilutes accumulated toxic material, facilitating easier removal and preventing solid particles from obstructing drainage holes, ensuring continuous fluid drainage throughout treatment. The combination of automated irrigation and controlled drainage in IRRAflow results in fewer complications and more thorough drainage.
In June 2023, Luciole Medical AG, a medical technology company headquartered in Switzerland, acquired Spiegelberg GmbH & Co. KG for an undisclosed sum. This acquisition will see the integration of their product ranges, manufacturing capacities, and distribution channels, harnessing their respective strengths with the goal of emerging as leaders in the development of next-generation brain monitoring devices. Spiegelberg GmbH & Co. KG is a German company known for its provision of catheters and external ventricular drainage kits.
Major companies operating in the external ventricular drain market are Medtronic Plc, B. Braun SE, Terumo Corporation, Getinge AB, Elekta AB, Integra LifeSciences, ABIOMED, Raumedic AG, Natus Medical Inc., Sophysa, Fuji Systems, Neuromedex GmbH, Ark BioSciences Inc., SILMAG S.A., Spiegelberg GmbH & Co. KG, Moller Medical GmbH, Dispomedica GmbH, IRRAS AB, Luciole Medical AG, Dispomedica GmbH
North America was the largest region in the external ventricular drain market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the external ventricular drain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the external ventricular drain market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The external ventricular drain market consists of sales of drainage systems, catheters, valve mechanisms, ICP monitors and transducers, and fixation devices. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
External Ventricular Drain Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on external ventricular drain market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for external ventricular drain ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The external ventricular drain market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.